Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3

  1. Rugo, H.S.
  2. Huober, J.
  3. García-Sáenz, J.A.
  4. Masuda, N.
  5. Sohn, J.H.
  6. Andre, V.A.M.
  7. Barriga, S.
  8. Cox, J.
  9. Goetz, M.
Revue:
Oncologist

ISSN: 1549-490X 1083-7159

Année de publication: 2021

Volumen: 26

Número: 1

Pages: e53-e65

Type: Article

DOI: 10.1002/ONCO.13531 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable